Русский
Analysis of satisfaction with drug therapy for anemia in patients with stage 5 chronic kidney disease on hemodialysis
DOI: https://dx.doi.org/10.18565/nephrology.2022.4.5-12
Kotenko O.N., Abolyan L.V., Kuteinikov V.Yu., Vinogradov V.E., Dorofeeva E.G.
1) Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology, City Clinical Hospital № 52 of the Moscow Healthcare Department, Moscow, Russia; 2) Sechenov University, Moscow, Russia; 3) Research Institute of care Organization and Medical Management of the Moscow Healthcare Department, Moscow, Russia
Objective. Comprehensive analysis of satisfaction with drug therapy for anemia in patients with stage 5 chronic kidney disease (CKD) on hemodialysis (HD), taking into account the medical and demographic characteristics of patients, achieved Hb levels, adherence to treatment and health-related quality of life (QoL).
Material and methods. In the period from August to November 2021, a survey of patients with stage 5 CKD on HD was conducted. The total number of respondents was 515 patients. The DTSQ (modified) and KDQOL questionnaires were used to assess satisfaction with treatment and QoL of patients.
Results. A significant positive correlation between patient satisfaction with drug therapy for anemia, Hb level, adherence to treatment, quality of life, material wealth and living conditions of patients was found.
Conclusion. Comprehensive assessment of satisfaction with drug therapy for anemia among patients with stage 5 CKD on HD is of great importance in the evaluation and selection of effective methods of treatment.
About the Autors
Oleg N. Kotenko – Cand.Sci. (Med.), Deputy Chief Physician for Nephrology, City Clinical Hospital № 52 of the Moscow Healthcare Department, Chief External Expert in Nephrology of the Moscow Healthcare Department, Moscow; Address: 3 Pekhotnaya st., Moscow, 123182. e-mail: olkotenko@yandex.ru. ORCID: 0000-0001-8264-7374. Lyubov V. Abolyan – Dr.Sci. (Med.), Professor at the Department of Public Health and Healthcare named after. N.A. Semashko, Sechenov University, Moscow. Address: Building 2, 2 Bolshaya Pirogovskaya st., Moscow, 119992; e-mail: labolyan@mail.ru. ORCID: 0000-0002-7644-8771.
Vladislav Yu. Kuteyinikov – Postgraduate Student at the Department of Public Health and Healthcare named after N.A.Semashko, Sechenov University, Moscow. Address: Address: Building 2, 2 Bolshaya Pirogovskaya st., Moscow, 119992: e-mail: vladislav864vlad@list.ru. ORCID: 0000-0002-6299-4261.
Vladimir E. Vinogradov – Head of the Consultative and Diagnostic Nephrology Department, City Clinical Hospital № 52 of the Moscow Healthcare Department, Specialist at the Organizational and Methodological Department for Nephrology, Research Institute of Healthcare Organization and Medical Management of the Moscow Healthcare Department, Moscow; Address: 3 Pekhotnaya st., Moscow, 123182. e-mail: vino-gradoff@yandex.ru. ORCID: 0000-0002-2499-4770.
Ekaterina G. Dorofeeeva – Nephrologist, Consultative and Diagnostic Nephrology Department, City Clinical Hospital № 52 of the Moscow Healthcare Department, Moscow, e-mail: egdorofeeva@bk.ru. Address: 3 Pekhotnaya st., Moscow, 123182. ORCID: 0000-0002-8764-4495.
Similar Articles
